A good little write up in the afr today (page 25), saying brokers believe insto's will take more interest in acl. It also states that gsk is Alchemia's partner (which is incorrect, of course).
I can't post, as I don't have on-line access.
I sure looks like the new ceo is going to keep the market more informed, which is a good thing.
The drums should start to roll as we near phase 2 results at the end of May.
- Forums
- ASX - By Stock
- fantastic cancer results
A good little write up in the afr today (page 25), saying...
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online